STMN1 and ovarian carcinoma: In conclusion, although no significant associations were observed between the genotype of stathmin and clinical characteristics or outcomes in patients with ovarian cancer in the present study, the results provided information concerning somatic or genetic variations of stathmin in patients with ovarian cancer.